Please assess the completion status of the following clinical trial:

Trial Title: The Triple A Initiative Study (Aktionsbündnis Akute Atemnot)

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: DIAGNOSTIC
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* acute dyspnea (NYHA II-IV)~* age \>= 18 years~* informed consent~Exclusion Criteria:~* cardiopulmonary resuscitation \< 7 days~* cardiogenic shock, STEMI, respiratory failure, or other clinical conditions that require immediate intensive care admission or angioplasty~* systolic blood pressure lower than 100 mmHg at first contact/presentation~* ventricular tachycardia~* severe aortic stenosis~* advanced neoplasm (e.g. lung cancer, hematologic neoplasm, etc.)~* chronic kidney disease requiring hemodialysis

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- default group (Type: NO_INTERVENTION): Patients with the randomization result default group receive standard diagnostics
- POCT group (Type: ACTIVE_COMPARATOR): patients with the randomization result POCT group receive a NTproBNP measurement with point of care device Cobash232 in the ambulance vehicle

Based on this trial design, predict the completion outcome and termination type (if applicable).